Skip to content
Nonsterile Compounding Home Study | 11-Hour PTCB-Recognized CE
This knowledge-based, enduring home study is designed for compounding pharmacists and pharmacy technicians seeking a comprehensive foundation in nonsterile compounding practices. The program provides a broad overview of nonsterile compounding, with a strong focus on regulatory compliance, standards, dosage forms, and pharmaceutical calculations essential to safe and effective compounding.
Participants will review the regulatory landscape governing nonsterile compounding, including applicable federal and state considerations and key United States Pharmacopeia (USP) standards, with emphasis on USP <795>. The program also addresses the roles and responsibilities of compounding personnel, facility and equipment requirements, documentation, quality assurance, and patient safety considerations.
The curriculum includes in-depth discussions of the most common nonsterile dosage forms prepared by compounders, such as solutions, suspensions, topical preparations, capsules, suppositories, transdermal preparations, and tablet triturates. Each section explores formulation principles, preparation techniques, and quality control measures relevant to practice.
A dedicated pharmaceutical calculations module provides detailed explanations and practical examples to help learners develop proficiency in calculations commonly used in compounding. This module serves as a guide to reinforce accuracy, consistency, and confidence in compounding calculations.
This 11-hour knowledge-based home study is a PTCB-Recognized Education/Training Program, ensuring a quality and standardized learning experience for pharmacy technicians. The program is offered in a self-paced, text-based format and does not include a video component, allowing learners to complete the material on their own schedule.
Build a strong foundation in nonsterile compounding and strengthen your skills in compliance, dosage forms, and pharmaceutical calculations—registration is below.
What participants said:
- “Covered all of the material in an effective manner.”
- “Several topics were covered in detail.”
- “I could complete the program at my own pace, which allowed me to take the time needed to fully process and understand the material.”
Note: It is not necessary to create a Lecture Panda account to register for this home study.
The American College of Apothecaries (ACA) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACA has accredited this knowledge-based program for 11 contact hours (1.1 CEUs) of continuing education credit for pharmacists and pharmacy technicians.
Register of Historic Places and is world-famous for its five resident Mallard ducks, who march daily through the lobby at 11am and 5pm.
Martha M. Rumore, PharmD, Esq, MS, LLM, FAPhA is a pharmacist-attorney in Frier Levitt’s Life Sciences Department. She is also a registered patent attorney and leads the firm’s Intellectual property team. She has broad and in-depth healthcare and regulatory experience. Her practice focuses on intellectual property (patents, trademarks, copyrights, trade secrets) and healthcare law, Food, Drug, Device & Cosmetic law (all facets-483s to clinical trials to registrations and product approval), pharmacy law and regulatory issues, 503A/503B compounding, Board of Pharmacy (licensing and disciplinary matters), PBM audits, and DSCSA supply chain compliance. Dr. Rumore has over 25 years of health-system, pharmaceutical industry, and law firm experience in the area of Food, Drug & Cosmetic Law, and pharmaceutical intellectual property Dr. Rumore is fluent in cGMPs, GCPs, writing and reviewing Clinical Trial Agreements (CTAs), Investigator brochures, manuscripts, labeling & advertising review, NDAs, study reports, and documents for regulatory submissions. She often prepares legal memoranda on healthcare/FDA matters and conducts Mock State Board of Pharmacy and FDA inspections for compounding pharmacies. Dr. Rumore has practiced both pharmacy and law. She has actual experience as a compounding pharmacist. She regularly counsels on Section 503A and state-specific compounding requirements, assesses compounding practices for state and federal regulatory compliance, including USP 797/795/800, medical necessity documentation, advertising & promotion, reimbursement issues, infrastructure, and preparing compounding policies and procedures that provide clear guidelines, standards, and training for staff. Previously, she was at the Director level in Drug Regulatory Affairs/Compliance in the pharmaceutical industry and hospital pharmacy. She taught Pharmacy Law, Drug Regulatory Affairs, and Food Drug & Cosmetic Law at several New York Colleges of Pharmacy and currently teaches Food, Drug & Cosmetic Law at Maurice A. Deane School of Law at Hofstra University. She is a frequent lecturer and has over 200 publications and presentations.
